化疗(Chemotherapy)和分子靶向治疗（Targeted Molecular Therapy）：过去认为化疗对脑转移瘤无效的概念，近来被新的研究成果所动摇。
基于108个网页-相关网页
molecular targeted therapy 分子靶向治疗 ; 神经生理干细胞乱疗 ; 肿瘤的分子靶向治疗
Molecular Targeted Cancer Therapy 肿瘤分子靶向治疗学
It is a key task for cancer research to search novel prognostic marker, improve early diagnostic rate, and new target of molecular targeted therapy of gastric cancer.
因此提高胃癌的早期诊断率、寻找新的治疗靶点及预后指标，是当前肿瘤研究的重要课题。
KRAS mutation frequency in tumor tissue, can be predicted non-small cell lung cancer molecular targeted therapy efficacy and prognosis, and molecular inhibitors of RAS genes is still in its infancy.
KRAS基因突变在恶性肿瘤组织中频发，可预测非小细胞肺癌分子靶向治疗的疗效和预后，针对RAS基因的分子抑制剂研究仍处于初级阶段。
Molecular targeted therapy has limited or nonexistent side effects on normal cells of the body, unlike traditional chemotherapy.
分子靶向治疗比传统的化疗特异性强、毒副反应小，将成为今后肿瘤治疗的新趋势。
应用推荐